Clinical trial Recruiting at 1 site Interventional Ages 55 and up

Using exergames to support older adults with psychosis

Official title: Feasibility of Exergame-based Cognitive-motor Training in Older Psychotic Inpatients: a Randomized Controlled Trial

Run by University Psychiatric Clinics Basel · NCT07060742 · Data updated 2026-11-12

This project will test whether combining exergames with a falls-prevention program can help people aged 55 and older with psychosis improve mobility, thinking, and everyday functioning.

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment32 (estimated)
SponsorUniversity Psychiatric Clinics Basel
Research network
Locations1 site (Basel, Canton of Basel-City)
StatusRecruiting
StartedJune 9, 2025
Main results expectedMay 15, 2027
Study endsMay 15, 2028
Registry record updatedJuly 16, 2025
Trial IDNCT07060742 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 55 or older with a diagnosed psychotic disorder who can give informed consent, speak German, have a MoCA score of 20 or above, and can stand for at least three minutes without support.

Probably not a fit

People with severe mobility, cognitive, sensory, or psychiatric limitations that prevent playing the exergames or completing assessments, those with insufficient German language skills, or those with MoCA scores below 20 are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program pairs Dividat Senso exergames with the OTAGO falls-prevention program for older adults who have psychotic disorders. Participants who can consent, speak German, are aged 55 or older, have a MoCA score of 20 or higher, and can stand unassisted for at least three minutes will take part in supervised, in-person training sessions and pre/post assessments. Outcomes will include measures of balance, gait, cognitive performance, fall risk, and daily functioning. The approach targets physical and cognitive rehabilitation alongside standard psychiatric care to address mobility decline, cognitive symptoms, and social isolation common in this group.

Why it matters

Potential benefit: If successful, this approach could improve balance and cognition, reduce fall risk, and enhance daily functioning and quality of life for older adults with psychosis.

How similar studies have gone: Some studies in older adults and in people with cognitive impairment suggest exergames can improve balance and cognition, but applying this combined exergame-plus-falls-prevention approach specifically to older adults with psychosis is relatively novel and not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed psychotic disorders
* Able to provide a signed informed consent
* Age ≥ 55 years
* MoCA ≥ 20
* Physically able to stand for at least 3 minutes without external support (self-report)

Exclusion Criteria:

* Insufficient knowledge of the German language to understand the instructions, the games, and the assessments
* Mobility, cognitive, sensory and/or psychiatric limitations or comorbidities that impair the ability to play the exergames and/or conduct the pre-/post assessments

Where it's running

  • Universitäre Psychiatrischen Kliniken (UPK) Basel
    Basel, Canton of Basel-City, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.